Myeloma Crowd Radio: Dr. Djordje Atanackovic, MD, Huntsman Cancer Institute

With the explosion in immunotherapies for multiple myeloma, we have heard there are "windows" of best and most effective use. What are those windows and when is the best time to use these new approaches? The field is ever growing and Dr. Djordje Atanackovic will share how and when to use these new tools for a myeloma patient's best care.  Thanks to our episode sponsor, Takeda Oncology